- Home
- SLM vs ITGR Comparison
SLM vs ITGR Comparison
Compare SLM & ITGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SLM | ITGR |
|---|---|---|
| Founded | 1972 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 4.3B |
| IPO Year | 1997 | 2000 |
Fundamental Metrics
Financial Performance| Metric | SLM | ITGR |
|---|---|---|
| Price | $18.85 | $126.61 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 10 | 9 |
| Target Price | $25.30 | ★ $121.80 |
| AVG Volume (30 Days) | ★ 3.2M | 715.1K |
| Earning Date | 10-22-2026 | 11-10-2026 |
| Dividend Yield | ★ 2.65% | N/A |
| EPS Growth | ★ 29.10 | N/A |
| EPS | ★ 1.68 | 1.17 |
| Revenue | N/A | ★ $1,853,637,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.25 | $5.96 |
| P/E Ratio | ★ $11.65 | $108.16 |
| Revenue Growth | N/A | ★ 7.98 |
| 52 Week Low | $17.77 | $62.00 |
| 52 Week High | $31.06 | $126.83 |
Technical Indicators
Market Signals| Indicator | SLM | ITGR |
|---|---|---|
| Relative Strength Index (RSI) | 23.66 | 67.55 |
| Support Level | $17.77 | $126.16 |
| Resistance Level | $23.21 | $126.80 |
| Average True Range (ATR) | 0.79 | 0.14 |
| MACD | -0.24 | -0.15 |
| Stochastic Oscillator | 0.88 | 43.94 |
Price Performance
Historical ComparisonAbout SLM SLM Corporation
SLM Corp is an education solutions company. Its business is to originate and service loans to students and their families to finance the cost of their education. The term' Private Education Loans to mean education loans to students or their families that are not made, insured, or guaranteed by any state or federal government.
About ITGR Integer Holdings Corporation
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns maximum of its revenue in the United States, and also has its presence in Ireland, Puerto Rico, Costa Rica, and Rest of the World.